Anemia in Critical Illness
نویسندگان
چکیده
منابع مشابه
Predicting late anemia in critical illness
INTRODUCTION Identifying critically ill patients most likely to benefit from pre-emptive therapies will become increasingly important if therapies are to be used safely and cost-effectively. We sought to determine whether a predictive model could be constructed that would serve as a useful decision support tool for the pre-emptive management of intensive care unit (ICU)-related anemia. METHOD...
متن کاملAnemia of Critical Illness: Prevention and Treatment 87 ANEMIA OF CRITICAL ILLNESS: PREVENTION AND TREATMENT Pharmacotherapy Self-Assessment Program, 5th Edition
1. Detect the pathophysiologic cause(s) of anemia in critically ill patients and assess the risks associated with its development. 2. Assess for the presence of anemia of critical illness in patients using clinical and laboratory indicators. 3. Assess the risks and benefits associated with the various treatment strategies for anemia of critical illness. 4. Develop patient-specific therapeutic p...
متن کاملLactate in critical illness
Lactate measurement in the critically ill has been traditionally used to stratify patients with poor outcome. However, plasma lactate levels are the result of a finely tuned interplay of factors that affect the balance between its production and its clearance. When the oxygen supply does not match its consumption, organisms such as man who are forced to produce ATP for their integrity adapt in ...
متن کاملCritiCal illness in pregnanCy
Critical illness in pregnancy increases maternal and fetal morbidity and mortality. The critical illness can be related to pregnancy per se, or can be secondary to a concurrent medical illness. Early identification and appropriate management results in good outcomes with a short ICU stay. Late identification and delayed therapy results in poor maternal & fetal outcomes with development of multi...
متن کاملScience review: Recombinant human erythropoietin in critical illness: a role beyond anemia?
Erythropoiesis usually fails during severe illness because of a blunting of the kidney-erythropoietin (EPO)-bone marrow axis. In this setting, clinical studies have shown that recombinant human erythropoietin (rhEPO), administered in pharmacological amounts, significantly reduces the need for blood transfusions. In addition to the kidney, however, EPO is also produced locally by other tissues i...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: American Journal of Respiratory and Critical Care Medicine
سال: 2012
ISSN: 1073-449X,1535-4970
DOI: 10.1164/rccm.201110-1915ci